Don’t invest unless you’re prepared to lose all your money. These are high-risk investments and you are unlikely to be protected if something goes wrong.

Aquarate is preventing hydration-related illness through sensor based technology and products.

aquarate nurse and patient
aquarate-text

Founder

Rebecca Taylor

Industry

Digital Health

Website

aquarate logo

Startup opportunity

Poor fluid balance monitoring (the control of water levels within the body) is a problem that costs the NHS and private care facilities over a billion pounds per year within the UK. The current system is reliant on nurses verbally asking patients how much they’ve had to drink, or guesstimating this based on water displacement. Unsurprisingly this is highly inaccurate, time-consuming and has detrimental effects on patient care.

Aquarate founder Rebecca Taylor came to the team now at The Venture Studio having extensively researched this area for her final year University project. She knew that there was a better way to do this, and believed the solution could be achieved through sensor-based technology.

aquarate cups

Since the fund’s investment and working with the team at  The Venture Studio

  • Validated concepts, designs and prototypes through industry user groups
  • Design and production of tech hardware – Mug, Cup and Charging Tray
  • Developed web app monitoring software for patients and carers
  • Creation of brand, website & go to market strategy
  • Secured trials in major UK hospital and care facilities
  • Submitted patent and IP protection applications
aquarate-founder

“Startups can be a lonely venture, but with The Venture Studio as my co-founder I’ve had a passionate team engaging with me throughout the process. I’ve been able to take an idea surrounding a known problem and follow it through to a tested and validated solution”

Rebecca Taylor, founder of Aquarate

awards 2021
RISK WARNING

Investing in start-ups and early-stage companies involves risks, including illiquidity, lack of dividends, loss of investment and dilution. It should be done only as part of a diversified portfolio. There is no assurance that the investment objectives of any investment opportunity will be achieved or that the strategies and methods described herein will be successful. Past performance is not necessarily a guide to future performance and the value of an investment may go down as well as up.

The investments which we promote are targeted exclusively at investors who understand the risks of investing in early-stage businesses and can make their own investment decisions. Any pitches for investment are not offers to the public and investments can only be made through Sapphire Capital Partners LLP as the fund manager. Neither Built Venture Capital Limited, Sapphire Capital Partners LLP, nor any of their members, directors or employees provide any financial, legal or tax advice in relation to the investments, and investors are recommended to seek independent advice before committing or if they have any doubts as to the appropriateness or suitability of such an investment in relation to their specific circumstances.

Built Ventures is a trading name for Built Venture Capital Limited. Built Venture Capital Limited is a private limited company registered in England and Wales (Company Number 11591402). Built Venture Capital Limited (FRN 826519) is an Appointed Representative of Sapphire Capital Partners LLP (FRN: 565716), who is authorised and regulated by the Financial Conduct Authority.

Built Ventures Footer Logo

Registered address: Built Ventures, 57 Jordan Street, Liverpool, Merseyside, England, L1 0BW

© BUILT VENTURES 2024